News | May 19, 2022
Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals
The latest certification endorses product for cold chain monitoring across 194 WHO member countries
As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications
The curriculum has been curated for General Physicians working in Clinikk
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Multiples is the first private equity (PE) investor in the company
The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology
Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program
WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products
Subscribe To Our Newsletter & Stay Updated
